[1] |
HUANG S, SONG J, HE C, et al. Genetic insights, di-sease mechanisms,and biological therapeutics for Waardenburg syndrome[J]. Gene Ther, 2022, 29 (9) :479-497.
|
[2] |
ROJAS R A, KUTATELADZE A A, PLUMMER L, et al. Phenotypic continuum between Waardenburg syndrome and idiopathic hypogonadotropic hypogonadism in humans with SOX10 variants[J]. Genet Med, 2021; 23(4):629-636.
|
[3] |
LI Y, CHEN Y, SUN Y, et al. Waardenburg syndrome type 2 with a de novo variant of the SOX10gene: a case report[J]. BMC Med Genomics, 2024, 17(1):104-111.
|
[4] |
任洁, 闫旭红, 张梦瑶, 等. 瓦登伯格综合征伴性腺功能减退症1例并文献复习[J]. 中国临床案例成果数据库, 2023, 05(01):E02338-E02338.
|
|
REN J, YAN X H, ZHANG M Y, et al. Vardenberg syndrome with hypogonadism: a case report and literature review[J]. China Clin Case Database, 2023, 5(1):E02338-E02338.
|
[5] |
WANG S Q, CHEN Y, LUO K H, et al. Diagnosis and genetic analysis of a case of Waardenburg syndrome type 2 with hypogonadotropic hypogonadism caused by SOX10 gene deletion[J]. Yi Chuan, 2022, 44(12):1158-1166.
|
[6] |
CHEN K, WANG H, LAI Y, et al. Kallmann syndrome due to heterozygous mutation in SOX10 coexisting with Waardenburg syndrome type Ⅱ: case report and review of literature[J]. Front Endocrinol, 2021, 11:592831.
|
[7] |
WANG F, ZHAO S, XIE Y, et al. De novo SOX10 Nonsense Mutation in a Patient with Kallmann Syndrome, Deafness, Iris Hypopigmentation, and Hyperthyroidism[J]. Ann Clin Lab Sci, 2018, 48(2):248-252.
pmid: 29678855
|
[8] |
IZUMI Y, MUSHA I, SUZUKI E, et al. Hypogonadotropic hypogonadism in a female patient previously diagnosed as having waardenburg syndrome due to a SOX10 mutation[J]. Endocrine, 2015, 49(2):553-556.
doi: 10.1007/s12020-014-0434-4
pmid: 25273316
|
[9] |
SUZUKI E, I IZUMI Y, CHIBA Y, et al. Loss-of-function SOX10 mutation in a patient with Kallmann syndrome, hearing loss, and iris hypopigmentation[J]. Horm Res Paediatr, 2015, 84(3):212-216.
|
[10] |
VAARALAHTI K, TOMMISKA J, TILLMANN V, et al. De novo SOX10 nonsense mutation in a patient with Kallmann syndrome and hearing loss[J]. Pediatr Res, 2014, 76(1):115-116.
doi: 10.1038/pr.2014.60
pmid: 24769923
|
[11] |
PARRY D M, SAFYER A W, MULVIHILL J J. Waardenburg-like features with cataracts, small head size, joint abnormalities, hypogonadism, and osteosarcoma[J]. Med Genet, 1978, 15(1):66-69.
|
[12] |
KELSH R N. Sorting out SOX10 functions in neural crest development[J]. Bioessays, 2006, 28 (8) :788-798.
|
[13] |
PINGAULT V, ZERAD L, BERTANI-TORRES W, et al. SOX10: 20 years of phenotypic plurality and current understanding of its developmental function[J]. J Med Genet, 2022, 59 (2) :105-114.
|
[14] |
王思琪, 陈阳, 罗宽宏, 等. 一例SOX10基因缺失所致的Waardenburg综合征2型合并低促性腺激素性性腺功能减退症的诊断和基因检测分析[J]. 遗传, 2022, 44 (12) :1158-1166.
|
|
WANG S Q, CHEN Y, LUO K, et al. Diagnosis and gene detection analysis of a case of Waardenburg syndrome type 2 combined with hypogonadotropin hypogonadism caused by SOX10 gene deletion[J]. Heredity, 2022, 44 (12) :1158-1166.
|
[15] |
PINGAULT V, ENTE D, DASTOT-LE MOAL F, et al. Review and update of mutations causing Waardenburg syndrome[J]. Hum Mutat, 2010, 31(4):391-406.
doi: 10.1002/humu.21211
pmid: 20127975
|
[16] |
AMATO L G L, MONTENEGRO L R, LERARIO A M, et al. New genetic findings in a large cohort of congenital hypogonadotropic hypogonadism[J]. Eur J Endocrinol, 2019, 181 (2) :103-119.
doi: 10.1530/EJE-18-0764
pmid: 31200363
|
[17] |
BOEHM U, BOULOUX P M, DATTANI M T, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis,diagnosis and treatment[J]. Nat Rev Endocrinol, 2015, 11 (9) :547-564.
|
[18] |
YOUNG J, XU C, PAPADAKIS G E, et al. Clinical Mana-gement of Congenital Hypogonadotropic Hypogonadism[J]. Endocr Rev, 2019, 40(2):669-710.
|